Artelo Biosciences, Inc.
At Close: 4:00 PM
ARTL Stock Price Graph
ARTL Stock Price Today
Artelo Biosciences, Inc. (ARTL) stock rallied over 3.24% intraday to trade at $1.91 a share on NASDAQ. The stock opened with a gain of 1.08% at $1.87 and touched an intraday high of $1.97, rising 3.24% against the last close of $1.85. The Artelo Biosciences, Inc. in stock market went to a low of $1.84 during the session.
ARTL Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
ARTL Stock Price History Chart
505 Lomas Santa FeSolana Beach, CA 92075US
Contact #:858 925 7049
Sales or RevenueN/A
5Y Sales ChangeN/A
Fiscal Year EndsDec. 2022
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for prostate and breast cancer treatment, as well as for treating PTSD. Artelo Biosciences, Inc. has research collaboration with Trinity College Dublin to investigate ART27.13 for the treatment of cancer cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Frequently Asked Questions
What is the current Artelo Biosciences, Inc. (ARTL) stock price?
Artelo Biosciences, Inc. (NASDAQ: ARTL) stock price is $1.91 in the last trading session. During the trading session, ARTL stock reached the peak price of $1.97 while $1.84 was the lowest point it dropped to. The percentage change in ARTL stock occurred in the recent session was 3.24% while the dollar amount for the price change in ARTL stock was $0.06.
ARTL's industry and sector of operation?
The NASDAQ listed ARTL is part of Biotechnology industry that operates in the broader Healthcare sector. Artelo Biosciences, Inc. , a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system.
Who are the executives of ARTL?
Mr. Gregory D. Gorgas M.B.A.
Pres, Chief Executive Officer, Chief Financial Officer, Treasurer, Sec. & Director
Dr. Andrew Yates Ph.D.
Senior Vice President & Chief Scientific Officer
Mr. Jason H. Baybutt
Senior Vice President of Fin.
Mr. Gregory D. Gorgas M.B.A.
Pres, CEO, CFO, Treasurer, Sec. & Director
How ARTL did perform over past 52-week?
ARTL's closing price is 0.19% higher than its 52-week low of $1.39 where as its distance from 52-week high of $7.2 is -0.77%.
How many employees does ARTL have?
Number of ARTL employees currently stands at 7.00. ARTL operates from 505 Lomas Santa Fe</br>Solana Beach, CA 92075</br>US.
Link for ARTL official website?
Official Website of ARTL is: https://www.artelobio.com
How do I contact ARTL?
ARTL could be contacted at phone #858 925 7049 and can also be accessed through its website. ARTL operates from 505 Lomas Santa Fe</br>Solana Beach, CA 92075</br>US.
How many shares of ARTL are traded daily?
ARTL stock volume for the day was 17587.00 shares. The average number of ARTL shares traded daily for last 3 months was 21.4 Thousands.
What is the market cap of ARTL currently?
The market value of ARTL currently stands at $4.91 Million with its latest stock price at $1.91 and 2.86 Million of its shares outstanding.